✦ LIBER ✦

The Use Of Transarterial Chemoembolization For Treating Hepatocellular Carcinoma In The Seer-Medicare Population

✍ Scribed by Breunig, I.M.; Shaya, F.T.; Hanna, N.N.; Chirikov, V.V.; Seal, B.; Mullins, C.D.

Book ID: 122323968
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 420 KB
Volume: 16
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.03.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The outcomes of elderly patients with he

The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization

✍ Thomas Yau; Tzy Jyun Yao; Pierre Chan; Richard John Epstein; Kelvin K. Ng; Siu H 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB 👁 1 views

Predictors of repeat transarterial chemo

Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinoma

✍ White, Jared A.; Redden, David T.; Bryant, Mary Kate; Dorn, David; Saddekni, Sou 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Comparison of doxorubicin-eluting bead t

Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma

✍ M.D. Ferrer Puchol; C. la Parra; E. Esteban; M. Vaño; M. Forment; A. Vera; O. Co 📂 Article 📅 2011 🏛 Elsevier ⚖ 254 KB

Transarterial chemoembolization using do

Transarterial chemoembolization using docetaxel-loaded phytantriol cubic phase precursor for the treatment of hepatocellular carcinoma

✍ Ke Han; Zhouhua Wang; Xinsheng Peng; Bao Chen; Xinguo Wen; Yixuan Dong; Chuanbin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB

Underutilization of therapy for hepatoce

Underutilization of therapy for hepatocellular carcinoma in the medicare population

✍ Shimul A. Shah; Jillian K. Smith; YouFu Li; Sing Chau Ng; James E. Carroll; Jenn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 1 views

## Abstract ## BACKGROUND: The incidence of hepatocellular carcinoma (HCC) is increasing in the United States, and the care of these patients remains highly specialized and complex. Multiple treatment options are available for HCC but their use and effectiveness remain unknown. ## METHODS: Using

Improved efficacy of transarterial chemo

Improved efficacy of transarterial chemoembolization using warmed miriplatin for the treatment of hepatocellular carcinoma: intermediate term review

✍ Yasui, D.; Murata, S.; Onozawa, S.; Mine, T.; Ueda, T.; Yamaguchi, H.; Sugihara, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB